Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arena Pharmaceuticals Inc (NASDAQ:ARNA)

29.28
Delayed Data
As of 1:00pm ET
 +1.88 / +6.86%
Today’s Change
11.30
Today|||52-Week Range
29.54
+106.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.1B

Company Description

Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.

Contact Information

Arena Pharmaceuticals, Inc.
6154 Nancy Ridge Drive
San Diego California 92121-9604
P:(858) 453-7200
Investor Relations:

Employees

Shareholders

Other institutional39.40%
Mutual fund holders34.67%
Individual stakeholders--

Top Executives

Amit D. MunshiPresident, Chief Executive Officer & Director
Kevin R. LindChief Financial Officer & Executive Vice President
John AdamsHead-Scientific Affairs
Preston S. KlassenChief Medical Officer
Douglas A. BakanVice President-Technical Operations